210 related articles for article (PubMed ID: 26201290)
1. Melatonin as a preventive and curative therapy against pulmonary hypertension.
Maarman G; Blackhurst D; Thienemann F; Blauwet L; Butrous G; Davies N; Sliwa K; Lecour S
J Pineal Res; 2015 Oct; 59(3):343-53. PubMed ID: 26201290
[TBL] [Abstract][Full Text] [Related]
2. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
3. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.
Tanaka Y; Takase B; Yao T; Ishihara M
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
6. Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Chen S; Sun P; Li Y; Shen W; Wang C; Zhao P; Cui H; Xue JY; Du GQ
Eur J Pharmacol; 2022 Oct; 933():175262. PubMed ID: 36100129
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
8. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
[TBL] [Abstract][Full Text] [Related]
10. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
[TBL] [Abstract][Full Text] [Related]
11. A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
Delbeck M; Nickel KF; Perzborn E; Ellinghaus P; Strassburger J; Kast R; Laux V; Schäfer S; Schermuly RT; von Degenfeld G
Cardiovasc Res; 2011 Oct; 92(1):159-68. PubMed ID: 21676958
[TBL] [Abstract][Full Text] [Related]
12. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
13. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.
Redout EM; van der Toorn A; Zuidwijk MJ; van de Kolk CW; van Echteld CJ; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1038-47. PubMed ID: 20061549
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.
Oknińska M; Zambrowska Z; Zajda K; Paterek A; Brodaczewska K; Mackiewicz U; Szczylik C; Torbicki A; Kieda C; Mączewski M
Sci Rep; 2021 Sep; 11(1):18002. PubMed ID: 34504231
[TBL] [Abstract][Full Text] [Related]
16. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with probucol effectively inhibits progression of pulmonary hypertension in rats.
Irukayama-Tomobe Y; Sakai S; Miyauchi T
Life Sci; 2000 Sep; 67(16):2017-23. PubMed ID: 11072878
[TBL] [Abstract][Full Text] [Related]
18. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
[TBL] [Abstract][Full Text] [Related]
19. Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure.
Farahmand F; Malik A; Sharma A; Bagchi AK; Singal PK
Physiol Rep; 2021 Nov; 9(22):e15090. PubMed ID: 34816616
[TBL] [Abstract][Full Text] [Related]
20. A study on the involvement of GABA-transaminase in MCT induced pulmonary hypertension.
Lingeshwar P; Kaur G; Singh N; Singh S; Mishra A; Shukla S; Ramakrishna R; Laxman TS; Bhatta RS; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2016 Feb; 36():10-21. PubMed ID: 26608704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
